amosulalol has been researched along with Pheochromocytoma in 3 studies
amosulalol: RN given is for mono-HCl; structure given in first source
Pheochromocytoma: A usually benign, well-encapsulated, lobular, vascular tumor of chromaffin tissue of the ADRENAL MEDULLA or sympathetic paraganglia. The cardinal symptom, reflecting the increased secretion of EPINEPHRINE and NOREPINEPHRINE, is HYPERTENSION, which may be persistent or intermittent. During severe attacks, there may be HEADACHE; SWEATING, palpitation, apprehension, TREMOR; PALLOR or FLUSHING of the face, NAUSEA and VOMITING, pain in the CHEST and ABDOMEN, and paresthesias of the extremities. The incidence of malignancy is as low as 5% but the pathologic distinction between benign and malignant pheochromocytomas is not clear. (Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1298)
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 42-year-old woman with pheochromocytoma received preoperatively a combined alpha- and beta-adrenoceptor blocking agent, amosulalol, exerting some inhibitory action on both receptors." | 7.68 | Failure of blood pressure control by a new combined alpha- and beta-blocking agent (amosulalol) in a patient with pheochromocytoma. ( Irisawa, C; Kawamura, S; Nakada, T; Watanabe, H; Yamaguchi, T, 1991) |
| " In our patient, both YM-09538 and bunazosin were effective in controlling severe hypertension preoperatively." | 4.77 | Periodic fluctuation of blood pressure and its management in a patient with pheochromocytoma. Case report and review of the literature. ( Ohno, M; Oishi, S; Sasaki, M; Sato, T; Umeda, T, 1988) |
| "A 42-year-old woman with pheochromocytoma received preoperatively a combined alpha- and beta-adrenoceptor blocking agent, amosulalol, exerting some inhibitory action on both receptors." | 3.68 | Failure of blood pressure control by a new combined alpha- and beta-blocking agent (amosulalol) in a patient with pheochromocytoma. ( Irisawa, C; Kawamura, S; Nakada, T; Watanabe, H; Yamaguchi, T, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsuura, H | 1 |
| Koyama, S | 1 |
| Tsuchioka, Y | 1 |
| Yoshida, M | 1 |
| Kurogane, H | 1 |
| Yamaguchi, T | 1 |
| Irisawa, C | 1 |
| Watanabe, H | 1 |
| Kawamura, S | 1 |
| Nakada, T | 1 |
| Oishi, S | 1 |
| Sasaki, M | 1 |
| Ohno, M | 1 |
| Umeda, T | 1 |
| Sato, T | 1 |
1 review available for amosulalol and Pheochromocytoma
| Article | Year |
|---|---|
Periodic fluctuation of blood pressure and its management in a patient with pheochromocytoma. Case report and review of the literature.
Topics: Adrenal Gland Neoplasms; Antihypertensive Agents; Blood Pressure; Catecholamines; Ethanolamines; Hum | 1988 |
2 other studies available for amosulalol and Pheochromocytoma
| Article | Year |
|---|---|
[Effects of alpha-and beta-adrenoceptor blocking agent (YM-09538) upon the clinical features of a patient with pheochromocytoma].
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Blood Pre | 1982 |
Failure of blood pressure control by a new combined alpha- and beta-blocking agent (amosulalol) in a patient with pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Adult; Antihypertensive Agents; Ethanolamines; Female; Humans; Hypertension | 1991 |